Skip to content

Comparison of Robot-assisted Gait Training According to Gait Speed in Participants With Stroke

Comparison of Robot-assisted Gait Training According to Gait Speed in Participants With Stroke

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03991364
Enrollment
20
Registered
2019-06-19
Start date
2019-07-01
Completion date
2020-12-31
Last updated
2019-06-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

Robot-assisted gait training, stroke, gait speed

Brief summary

Comparison of the experimental group that applied the speed of the robot-assisted gait training constantly and the control group that applied the gradual increase of the speed of the robot-assisted gait training.

Interventions

OTHERConstant gait speed group

The speed of the robot-assisted gait treatment is constantly applied for 5 times a week for 2 weeks.

OTHERIncreasing gait speed group

The speed of the robot-assisted gait treatment is gradually increase for 5 times a week for 2 weeks.

Sponsors

National Rehabilitation Center, Seoul, Korea
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
19 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Hemiplegic patients secondary to first cerebrovascular accidents * Functional ambulation category score ≥ 3

Exclusion criteria

* History of surgery of affected lower limb * Fracture of affected lower limb

Design outcomes

Primary

MeasureTime frameDescription
Energy expenditure (EE)2 weeks after baselineEE(kcal/min): energy expenditure per minute

Secondary

MeasureTime frameDescription
Heart rate (HR)baseline, 1 weeks after baseline, 2 weeks after baseline, 3 weeks after baselineCardiac frequency
Volume of Oxygen (VO2)baseline, 1 weeks after baseline, 2 weeks after baseline, 3 weeks after baselineO2 consumption/1min
Respiratory Quotient (R)baseline, 1 weeks after baseline, 2 weeks after baseline, 3 weeks after baselineRespiratory quotient
Metabolic equivalent (METS)baseline, 1 weeks after baseline, 2 weeks after baseline, 3 weeks after baselinethe amount of oxygen consumed while sitting at rest and is equal to 3.5 ml O2 per kg body weight x min
oxygenated hemoglobin (OxyHb)baseline, 1 weeks after baseline, 2 weeks after baseline, 3 weeks after baselineoxygenated hemoglobin concentration of cortical activation
Energy expenditure (EE)baseline, 1 weeks after baseline, 3 weeks after baselineEE(kcal/min): energy expenditure per minute
Lower extremity Fugl-Meyer Assessmentbaseline, 1 weeks after baseline, 2 weeks after baseline, 3 weeks after baselineFugl-Meyer Assessment uses to examine the motor function and coordination of affected lower extremity. It includes 17 items of a 3-point ordinal scale, ranging 0-34, with higher scores indicating lower impairment.
Functional Ambulation Categorybaseline, 1 weeks after baseline, 2 weeks after baseline, 3 weeks after baselineFunctional Ambulation Category is used to assess gait ability with 6 levels ranging from 0 to 5 on the basis of the amount of physical support required, regardless of use of an assistive device
10m walk testbaseline, 1 weeks after baseline, 2 weeks after baseline, 3 weeks after baseline10m walk test is used to examine gait speed, in which participant was asked to walk on a 14 meter of walkway wearing harness with two conditions; with the fastest speed or with self-selected comfortable speed.
timed up and go testbaseline, 1 weeks after baseline, 2 weeks after baseline, 3 weeks after baselinesimple test used to assess a person's mobility and requires both static and dynamic balance
deoxygenated hemoglobin (DeoxyHb)baseline, 1 weeks after baseline, 2 weeks after baseline, 3 weeks after baselinedeoxygenated hemoglobin concentration of cortical activation

Countries

South Korea

Contacts

Primary ContactJoon-Ho Shin, MS
asfreelyas@gmail.com82-2-901-1884

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026